Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease. - Wikidata - wikimedia - TriplyDB

Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.

Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.

http://www.wikidata.org/entity/Q37190915

about

Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with Benznidazole Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis.NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection.Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.Optimisation of an Advanced Oxidation Protein Products Assay: Its Application to Studies of Oxidative Stress in Diabetes Mellitus Chemopreventive effect of methanolic extract of Azadirachta indica on experimental Trypanosoma brucei induced oxidative stress in dogs.Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns?Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.Developments in the management of Chagas cardiomyopathy.Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.S-Nitrosylation Proteome Profile of Peripheral Blood Mononuclear Cells in Human Heart Failure IL-6 Improves the Nitric Oxide-Induced Cytotoxic CD8+ T Cell Dysfunction in Human Chagas Disease.Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.Redox regulation of inflammation: old elements, a new story.An in vitro study ascertaining the role of H2O2 and glucose oxidase in modulation of antioxidant potential and cancer cell survival mechanisms in glioblastoma U-87 MG cells.Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease.Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation.Oxidative stress and autonomic nerve function in early type 1 diabetes.PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance.Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.Q58648633 Diet Modulates Adipose Tissue Oxidative Stress in a Murine Acute Chagas Model

P2860

Q28543851-1D851422-0193-42FD-8B33-55581F550043 Q33916310-3F8042C0-C447-4F21-A913-87BE3565229A Q34112124-C87A26FE-3BE1-4A4D-AEA0-4233EAE50467 Q34124960-DCBE0B7B-4B55-4C74-B3BE-E084FD593BC9 Q34163899-62EC07E8-2653-4590-A616-AE7FD32D3EC0 Q34250328-12CE8935-6C7D-498F-AE7C-09AF14A7BB90 Q34563670-FCAFACDA-9737-43F2-BDC1-AAFAB11FEAF4 Q34992879-7C1DA592-893D-4DE3-AA9E-0259C3FC89C3 Q35737933-8C453174-9E65-4610-A01A-737F392BF359 Q35753890-16EA3E4F-0456-421E-BC20-3548D8F183E6 Q35937562-E4C44F62-0334-4EF8-A8FE-0AAC3231E9BB Q36226034-D6900401-CFCB-46C6-81A5-3D8A90714C90 Q36504833-38ED7E09-A9CA-45A3-85BF-BADE57057DB8 Q36737035-F4DECB1B-2370-43DE-BD8E-8F0801EDC4E5 Q36904784-5794B8E5-0B99-4C1E-88A8-0B216939C30B Q37086096-68024DB9-6669-411F-825B-AEE2783FC491 Q37223016-E2E3CE78-658D-49FE-B377-C7DCFB2CAA0D Q37528583-F29AD5E5-2ED1-4E17-928C-338A05D87198 Q37821802-7E5A1A01-3DBA-4DA3-8EF7-9E58B5203950 Q38244572-8BD05A79-BC4C-4838-ABD5-C8E3D3D2EB32 Q38698133-FCC2BA5F-D0FD-4A75-ABB7-3E6800577EC8 Q39602017-F8316509-D818-423D-8865-6130086FEA4B Q41024376-79A2C5F7-C7A3-4F3E-B7CB-BEE2C1CBDD1F Q51152548-BE1C034F-15C7-4A8C-81FA-8EEB0C0F0BE7 Q55416701-172CA40A-EA39-400B-A0D9-B6C991AE7454 Q55426892-7C741F38-A171-4E79-A655-F498A1595049 Q58648633-E2E01BAD-399E-4909-8A79-22417A55E0A5 Q58842383-0D9B6D3F-C9F1-492D-AD0B-E500F31F1636

P2860

Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.

http://www.wikidata.org/entity/Q37190915

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@en

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@nl

type

label

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@en

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@nl

prefLabel

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@en

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@nl

P1433

Q37190915-D19E5A1A-D809-4311-BEF1-082B9C0F0C13

P1476

Q37190915-36726855-BC11-4A74-915A-0BFE14870740

P2093

Q37190915-1219BE7D-55A1-44DE-8D03-88CC4A92C4AF

Q37190915-15D62A55-C9B3-4302-88C7-9608B467B196

Q37190915-16B33511-FB49-4228-84F7-5A5201EE3792

Q37190915-2D64BD0D-F23E-4551-BAD5-E9B66A5DCE74

Q37190915-2F3D6545-9F9B-4DA3-A855-EA521084C89D

Q37190915-63B98568-C732-4FBE-BD53-90F3D00B5949

Q37190915-9F6C203F-C353-463E-BAAD-C2B251DC17C2

Q37190915-ACC03C0E-7BF5-4A41-85CB-4AFBE90C5D10

Q37190915-BED1E708-FE8C-4940-8263-46D53FC3E1FC

Q37190915-D3772AC9-6608-436A-8882-FADDC6CBAFB8

P2860

Q37190915-0AA11E9A-3C5F-40E5-BA49-28D1C733B622

Q37190915-0CFB1DF9-3542-4941-9EC9-7005E526D6DA

Q37190915-0E7EEB75-FD1C-4376-BD08-07A19E402C0A

Q37190915-1104A378-B761-4340-A137-13E46EA04EC4

Q37190915-17F83CF4-C371-493C-A1ED-88507C3C1DAF

Q37190915-1CE716BA-C9FB-43E3-81E3-D39D52173E22

Q37190915-23BBE1DD-B448-43B7-BEE4-340541E3BBAB

Q37190915-2A007C11-7F9F-4D05-B8FD-B7AE9203C9D8

Q37190915-394A60C7-35C1-40A2-A3E5-97E64BF948B3

Q37190915-43BF5396-8940-4FF3-808A-A3D281804CBB

P304

Q37190915-C193D6EB-A81E-4217-A553-A0D58B4554EB

P31

Q37190915-B8AD0D54-5C52-4855-B236-AB0257884BC6

P356

Q37190915-24D3CF46-AEA4-4228-A912-898685CE19B2

P433

Q37190915-0038E0FD-BE80-45F1-B304-6E25E00486B3

P478

Q37190915-B5894360-C937-4A44-987B-CB416B85363B

P577

Q37190915-1A42826A-0FB2-4779-834A-F4468AE9CBF7

P5875

Q37190915-468BAE8F-A425-40A8-AC89-5207964ACB40

P698

Q37190915-FD01444B-4090-4438-BD53-74EE0E651A57

P921

Q37190915-4B464A8A-AB0B-481E-B3EE-39C9F5B45870

Q37190915-BDF8C3C1-D9AC-46CD-8A61-EBC399060AB6

P932

Q37190915-5732C7DC-381D-4E94-8352-549676DC1320

P356

P1433

Clinical and Vaccine Immunology

P1476

Increased myeloperoxidase acti ...... patients with Chagas' disease.

@en

P2093

Francisco J Ramirez-Aguilar

http://www.w3.org/2001/XMLSchema#string

Gladys Perez-Molina

http://www.w3.org/2001/XMLSchema#string

Heidi Spratt

http://www.w3.org/2001/XMLSchema#string

Jasmine M Pando

http://www.w3.org/2001/XMLSchema#string

Jose Guillermo Estrada-Franco

http://www.w3.org/2001/XMLSchema#string

Monisha Dhiman

http://www.w3.org/2001/XMLSchema#string

Nisha Jain Garg

http://www.w3.org/2001/XMLSchema#string

Roberto Moreno

http://www.w3.org/2001/XMLSchema#string

Rosa Gallegos-Sandoval

http://www.w3.org/2001/XMLSchema#string

Sara Vazquez-Corzo

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative modification of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection

NADPH oxidase: an update

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease.

Myeloperoxidase.

Oxyradicals and DNA damage.

Biomarkers of myeloperoxidase-derived hypochlorous acid.

Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro.

The role of nitric oxide in the pathogenesis of Chagas disease.

Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease.

P304

660-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00019-09

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24211546

http://www.w3.org/2001/XMLSchema#string

P698

19297613

http://www.w3.org/2001/XMLSchema#string

P921

P932

2681587

http://www.w3.org/2001/XMLSchema#string